Neomycin, Polymyxin, and Bacitracin Ophthalmic
Neomycin, polymyxin B, and bacitracin is a triple-antibiotic combination used across ophthalmic and topical products to help prevent infection in minor cuts, scrapes, and burns.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 171 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Neomycin, Polymyxin, and Bacitracin Ophthalmic: Patient Information Guide
A plain-language walkthrough of Neomycin, Polymyxin, and Bacitracin Ophthalmic — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
This triple-antibiotic combination is available in eye and skin formulations for several different uses depending on the specific product.
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment is an eye-specific product used as an antibacterial treatment applied to the eye area.
- Topical skin products (Antibiotic, Circle K Triple Antibiotic, Crane Safety Triple Antibiotic, First Aid Antibiotic, Good Sense First Aid Antibiotic, Green Guard Triple Antibiotic) provide first aid to help prevent infection in minor cuts, scrapes, and burns.
- Several topical products also offer temporary relief of pain and itching associated with minor burns, cuts, scrapes, and insect bites.
- First Aid Antibiotic topical solution is used to prepare the skin before an injection and for antiseptic cleansing of the face, hands, and body.
⚙️How it works▾
Each of the three antibiotics targets bacteria in a different way, which is what makes this combination so effective across a broad range of germs. Neomycin binds to the bacteria's ribosomal RNA — the machinery they use to make proteins — causing errors that are fatal to the bacteria. Polymyxin B disrupts the outer membrane of gram-negative bacteria (a certain class of germs), making it leaky so the bacteria can't survive. Bacitracin blocks bacteria from rebuilding their cell walls, which they need to stay intact and reproduce.
Together, these three mechanisms are active against many gram-positive and gram-negative organisms, including Staphylococcus aureus, streptococci, Escherichia coli, Haemophilus influenzae, Klebsiella/Enterobacter species, Neisseria species, and Pseudomonas aeruginosa. The combination does not provide adequate coverage against Serratia marcescens.
💊How it's taken▾
For topical skin products, clean the affected area first and apply a small amount — roughly the surface area of a fingertip — up to 3 times daily. You can cover the area with a sterile bandage. Do not use for longer than 1 week unless your doctor directs otherwise, and do not apply over large areas of the body.
- Children under 2 years old should only use topical products under a doctor's supervision.
- First Aid Antibiotic topical solution for injection site prep: wipe the site vigorously and discard the applicator.
- First Aid Antibiotic topical solution cleansing towelette: use once and discard after single use.
- For the ophthalmic ointment, follow your prescriber's exact directions — do not substitute a skin product for the eye formulation.
🤒Side effects — in detail▾
Side effects can occur with any of the antibiotic components in this combination.
- Itching at the application site
- Swelling
- Redness (conjunctival erythema with the ophthalmic ointment)
- Local irritation on application
- Allergic sensitization reactions
More serious reactions — including anaphylaxis (a severe, whole-body allergic reaction) — have been reported rarely with the ophthalmic ointment. Stop using the product and seek medical attention right away if you develop significant swelling, a spreading rash, or trouble breathing.
⚠️Warnings & precautions▾
- For external use only — never swallow any form of this product. If swallowed, contact a Poison Control Center immediately.
- Topical skin products must not be used in the eyes — only the designated ophthalmic ointment is approved for eye use.
- Do not apply topical products over large areas of the body, on blistered or raw surfaces, or for more than 1 week without a doctor's approval.
- Some topical solution products are flammable — keep away from fire and flame, and do not use near electrocautery equipment.
- Stop use and contact a doctor if a rash or allergic reaction develops, if the condition gets worse, or if symptoms don't improve after 7 days.
- Do not use the ophthalmic ointment if you have a known allergy to any of its ingredients.
- Keep all products out of reach of children.
🔀What it interacts with▾
The FDA label for these products does not describe specific drug or food interactions.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you are allergic to neomycin, polymyxin B, bacitracin, or any other ingredient in the product.
- Ask a doctor before using topical products if you have deep or puncture wounds, animal bites, or serious burns — these need professional evaluation.
- Children under 2 years old: consult a doctor before using topical skin products.
- Do not use topical skin products in the eyes or over large areas of the body.
- Do not use topical solution on broken skin or deep puncture wounds.
- Keep all products out of reach of children.
🚑If you take too much▾
If any form of this product is accidentally swallowed, get medical help or contact a Poison Control Center right away. Do not wait for symptoms to appear.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F) .
📄 Written from Neomycin, Polymyxin, and Bacitracin Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Neomycin, Polymyxin, and Bacitracin Ophthalmic — the kind of thing our pharmacy team would talk through with you at the counter.
What's the difference between the eye ointment and the regular skin ointment — can I use one for both? ▾
How do I apply the skin ointment correctly? ▾
How long should I use this before I expect to see results? And when should I stop? ▾
Can this cause an allergic reaction? What should I watch for? ▾
Is this safe to use on my child? ▾
What if I accidentally get it in my eyes or someone swallows it? ▾
Is Neomycin, Polymyxin, and Bacitracin Ophthalmic available over the counter? ▾
When was Neomycin, Polymyxin, and Bacitracin Ophthalmic first available? ▾
Who makes Neomycin, Polymyxin, and Bacitracin Ophthalmic? ▾
💬 Answers drafted from Neomycin, Polymyxin, and Bacitracin Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Neomycin, Polymyxin, and Bacitracin Ophthalmic comes
Neomycin, Polymyxin, and Bacitracin Ophthalmic is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- First aid to help prevent infection in minor cuts, scrapes, and burns
- Temporary relief of pain and itching associated with minor burns, minor cuts, and scrapes
- Clean the affected area before applying
- Apply a small amount (about the size of a fingertip) to the area 1 to 3 times daily
- May be covered with a sterile bandage
- Do not use for longer than 1 week unless directed by a doctor; children under 2 years should use only under a doctor's direction
Show 27 more strengths Show fewer strengths
Eye ointment
How this form is used
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment is used as an eye-specific antibacterial treatment
- Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment is for ophthalmic (eye) use only — do not use a skin product in the eye
- Do not use if you are allergic to any of the ingredients
- Follow your prescriber's directions carefully for dosing and frequency
Topical solution
How this form is used
- First Aid Antibiotic topical solution is used to prepare the skin before an injection
- First Aid Antibiotic topical solution is used for antiseptic cleansing of the face, hands, and body
- First Aid Antibiotic topical solution helps prevent infection and provides temporary relief of pain and itching from minor burns, scrapes, and insect bites
- First Aid Antibiotic topical solution (injection prep): wipe the injection site vigorously with the product and discard
- First Aid Antibiotic topical solution (cleansing towelette): tear open the packet, unfold the towelette, cleanse the desired skin area, and discard after single use
- First Aid Antibiotic topical solution is flammable — keep away from fire or flame
- Avoid contact with eyes; if contact occurs, rinse thoroughly with water
📊 Neomycin, Polymyxin, and Bacitracin Ophthalmic across the U.S. market
How Neomycin, Polymyxin, and Bacitracin Ophthalmic appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Kit (3) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Neomycin, Polymyxin, and Bacitracin Ophthalmic is used
A general measure of how commonly Neomycin, Polymyxin, and Bacitracin Ophthalmic is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Neomycin, Polymyxin, and Bacitracin Ophthalmic is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Neomycin, Polymyxin, and Bacitracin Ophthalmic prescribed? Of the 1,594 medications we measure, Neomycin, Polymyxin, and Bacitracin Ophthalmic ranks #629 by Medicaid prescriptions — more than 61% of them.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Neomycin, Polymyxin, and Bacitracin Ophthalmic, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 12 of 361 listed Neomycin, Polymyxin, and Bacitracin Ophthalmic NDCs with Medicaid activity.
🔍 Compare Neomycin, Polymyxin, and Bacitracin Ophthalmic products
A representative set of FDA-listed product records for Neomycin, Polymyxin, and Bacitracin Ophthalmic — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye ointment | ||||
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Akorn | ANDA | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; BACITRACIN ZINC 400 [USP'U]/g | Ophthalmic | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Bausch & Lomb Incorporated × 2 listings | ANDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Casper Pharma LLC | NDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Henry Schein Inc. | ANDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Mwi | ANDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | A-S Medication Solutions × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | A-S Medication Solutions × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | A-S Medication Solutions | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 U/g; mg/g; U/g | Topical | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Acme United Corporation | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 417.8; 3.5; 5322.8 [IU]/g; mg/g; [IU]/g | Topical | Acme united Corporation | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Advanced First Aid, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Adventure Ready Brands | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Afassco Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Amazon.com Services LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Amazon.com Services LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | American Sales Company × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | American Sales Company | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | AmerisourceBergen | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | AmerisourceBergen | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Army & Air Force Exchange Service | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Army & Air Force Exchange Service | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bellegrove Medical Supply, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Bellegrove Medical Supply, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Bi-Mart | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bi-Mart Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bi-Mart Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bjwc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Bjwc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 U/g; mg/g; U/g | Topical | Cardinal Health | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cardinal Health (Leader) 70000 | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cardinal Health (Leader) 70000 | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Chain Drug Marketing Association × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Chain Drug Marketing Association | OTC MONOGRAPH DRUG | View NDC → |
| 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g | Topical | Chain Drug Marketing Association Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/g | Topical | Chain Drug Marketing Association Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | CMC Group, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | CMC Group, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Cosette Pharmaceuticals, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | Cosette Pharmaceuticals, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g; BACITRACIN ZINC 400 U/g | Topical | Cosmuses Cosmetics (Ningbo) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Crane Safety LLC × 5 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g | Topical | Crane Safety LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | CVS Health | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | CVS Pharmacy | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | CVS Pharmacy | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | CVS Pharmacy | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Dealmed Medical Supplies, LLC. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Dealmed Medical Supplies LLC | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Discount Drug Mart, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Dolgencorp, LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Dolgencorp, LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Dynarex Corporation × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Dynarex Corporation | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | Ecolabs Food Safety Specialties, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Ecolabs Food Safety Specialties, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Ecolabs Food Safety Specialties, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 0.0035 g/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Everlit Global Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Ever Ready × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 0.0035; 5000 [USP'U]/g; g/g; [USP'U]/g | Topical | Ever Ready First Aid | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 0.0035 g/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Ever Ready First Aid × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Express Companies, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Ezricare Llc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Ezricare Llc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Fourstar Group USA, Inc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Fourstar Group Usa, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Fred's, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Fred's, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 0.41 g/100 g; NEOMYCIN SULFATE 0.0035 g/100 g; POLYMYXIN B SULFATE 0.52 g/100 g | Topical | Front Pharmaceutical Plc | OTC MONOGRAPH DRUG | View NDC → |
| 0.41; 0.0035; 0.52 g/100 g; g/100 g; g/100 g | Topical | Front Pharmaceutical Plc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Front Pharmaceutical PLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Galentic Pharma (India) Private Limited | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B 5000 U/g | Topical | Gentell LLC | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Geri-Care Pharmaceuticals, Corp | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | GFA Production(Xiamen) Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | GFA Production (Xiamen) Co., Ltd. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | GFA Production (Xiamen) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | GFA Production (Xiamen) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Global Pharma Healthcare Private Limited | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Gobrands, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | H2-Pharma, LLC | OTC MONOGRAPH FINAL | View NDC → |
| POLYMYXIN B SULFATE 0.064 g/g; BACITRACIN ZINC 0.571 g/g; NEOMYCIN SULFATE 0.538 g/g | Topical | Harris Teeter Llc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | HART Health × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | H E B | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | H E B | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Henry Schein | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 50000 [IU]/g; mg/g; [IU]/g | Topical | Henry Schein | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Henry Schein | OTC MONOGRAPH DRUG | View NDC → |
| POLYMYXIN B SULFATE 50000 [IU]/g; NEOMYCIN SULFATE 5 mg/g; BACITRACIN ZINC 400 [IU]/g | Topical | Henry Schein | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Henry Schein, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Honeywell Safety Products USA, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 35; 5000 [IU]/g; mg/g; [IU]/g | Topical | Hubei Changjian Medical Products Co., Ltd. | OTC MONOGRAPH FINAL | View NDC → |
| 400; 35; 5000 [IU]/g; mg/g; [IU]/g | Topical | Hubei Changjian Medical Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 35 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Hubei Changjian Medical Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | HyVee Inc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [CFU]/g; mg/g; [CFU]/g | Topical | J&A Digital Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [CFU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [CFU]/g | Topical | J&A Digital Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/0.5 g; mg/0.5 g; [IU]/0.5 g | Topical | JHK Inc dba American Safety & First Aid | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/0.5 g; NEOMYCIN SULFATE 3.5 mg/0.5 g; POLYMYXIN B SULFATE 5000 [IU]/0.5 g | Topical | JHK Inc dba American Safety & First Aid | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Johnson & Johnson Consumer Inc. × 4 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Kareway Product, Inc. × 4 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Kenvue Brands LLC × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Kroger Company | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Kroger Company | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | L. Perrigo Company × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | L. Perrigo Company × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lidl US, LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Lidl US, LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil' Drug Store Products, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil' Drug Store Products, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/1; mg/1; [IU] | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/1; mg/1; [IU] | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | M-star (Hubei) Health&Care Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Major Pharmaceuticals | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Major Pharmaceuticals | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Major Pharmaceuticals × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Medline Industries, LP × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Medline Industries, LP | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Meijer Distribution Inc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Meijer Distribution Inc | OTC MONOGRAPH DRUG | View NDC → |
| 500; 3.5; 10000 U/g; mg/g; U/g | Topical | Melaleuca, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 500 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 U/g | Topical | Melaleuca, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 0.0035; 5000 [USP'U]/g; g/g; [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 0.0035; 5000 [USP'U]/g; g/g; [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 0.0035 g/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. × 9 listings | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g | Topical | Nantong Health & Beyond Hygienic Products Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 U/9.4 g; mg/9.4 g; U/9.4 g | Topical | Natureplex LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/9.4 g; NEOMYCIN SULFATE 3.5 mg/9.4 g; POLYMYXIN B SULFATE 5000 U/9.4 g | Topical | Natureplex LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | New World Imports, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | New World Imports, Inc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | New World Imports, Inc × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | NuCare Pharmaceuticals,Inc. | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | NuCare Pharmaceuticals,Inc. | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Ol Pharma Tech, Llc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/g | Topical | Ol Pharma Tech, Llc | OTC MONOGRAPH DRUG | View NDC → |
| 💊Topical solution | ||||
| 400; 3.5; 5000 U/g; mg/g; U/g | Topical | Hubei Fanjian Medical Product Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Hubei Fanjian Medical Product Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| 💊Kits | ||||
| — | — | GFA Production (Xiamen) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| — | — | Johnson & Johnson Consumer Inc. | OTC MONOGRAPH DRUG | View NDC → |
| — | — | Kenvue Brands LLC | OTC MONOGRAPH DRUG | View NDC → |
Showing 200 of 383 products — FDA National Drug Code Directory. See every product, package size and price: browse all 383 Neomycin, Polymyxin, and Bacitracin Ophthalmic NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Neomycin, Polymyxin, and Bacitracin Ophthalmic — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Neomycin, Polymyxin, and Bacitracin Ophthalmic in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Neomycin, Polymyxin, and Bacitracin Ophthalmic went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
📦 Supply & shortage status
Whether Neomycin, Polymyxin, and Bacitracin Ophthalmic is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Neomycin, Polymyxin, and Bacitracin Ophthalmic belongs to the Other antibiotics for topical use class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 171 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Mwi is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.